Topilsky M - Search Results

1

Chest wall shrapnel-induced beryllium-sensitization and associated pulmonary disease.

Fireman E, Shai AB, Lerman Y, Topilsky M, Blanc PD, Maier L, Li L, Chandra S, Abraham JM, Fomin I, Aviram G, Abraham JL. Fireman E, et al. Among authors: topilsky m. Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct;29(2):147-50. Sarcoidosis Vasc Diffuse Lung Dis. 2012. PMID: 23461078 Free PMC article.

2

Sarcoidosis: an organized pattern of reaction from immunology to therapy.

Fireman EM, Topilsky MR. Fireman EM, et al. Among authors: topilsky mr. Immunol Today. 1994 May;15(5):199-201. doi: 10.1016/0167-5699(94)90242-9. Immunol Today. 1994. PMID: 7912935

3

Induced sputum compared to bronchoalveolar lavage for evaluating patients with sarcoidosis and non-granulomatous interstitial lung disease.

Fireman E, Topilsky I, Greif J, Lerman Y, Schwarz Y, Man A, Topilsky M. Fireman E, et al. Among authors: topilsky m, topilsky i. Respir Med. 1999 Nov;93(11):827-34. doi: 10.1016/s0954-6111(99)90269-x. Respir Med. 1999. PMID: 10603633 Free article. Clinical Trial.

4

Evaluation of workers exposed to dust containing hard metals and aluminum oxide.

Schwarz Y, Kivity S, Fischbein A, Abraham JL, Fireman E, Moshe S, Dannon Y, Topilsky M, Greif J. Schwarz Y, et al. Among authors: topilsky m. Am J Ind Med. 1998 Aug;34(2):177-82. doi: 10.1002/(sici)1097-0274(199808)34:2<177::aid-ajim11>3.0.co;2-s. Am J Ind Med. 1998. PMID: 9651628

5

Suppressor cell activity of human alveolar macrophages in interstitial lung diseases.

Fireman EM, Ben Efraim S, Greif J, Kivity S, Topilsky MR. Fireman EM, et al. Among authors: topilsky mr. Clin Exp Immunol. 1988 Jul;73(1):111-6. Clin Exp Immunol. 1988. PMID: 2971484 Free PMC article.

6

Continued progression of asbestos-related respiratory disease after more than 15 years of non-exposure.

Bar-Shai A, Tiran B, Topilsky M, Greif J, Fomin I, Schwarz Y. Bar-Shai A, et al. Among authors: topilsky m. Isr Med Assoc J. 2012 Sep;14(9):560-5. Isr Med Assoc J. 2012. PMID: 23101420 Free article.

7

Release of PGE2 and IL-1 as related to suppressive activity of alveolar macrophages from interstitial lung diseases.

Fireman E, Ben-Efraim S, Topilsky M. Fireman E, et al. Among authors: topilsky m. Agents Actions. 1989 Jan;26(1-2):173-4. doi: 10.1007/BF02126598. Agents Actions. 1989. PMID: 2785334 No abstract available.

8

Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell-to-cell contact.

Fireman E, Ben-Efraim S, Spinrad S, Topilsky M, Greif J. Fireman E, et al. Among authors: topilsky m. Eur Respir J. 1993 Jul;6(7):956-64. Eur Respir J. 1993. PMID: 8370444

9

Cholesterol crystals in BAL fluid from patients with idiopathic pulmonary fibrosis.

Fireman E, Spitzer S, Grief J, Kivity S, Topilsky M. Fireman E, et al. Among authors: topilsky m. Respir Med. 1996 Jul;90(6):361-3. doi: 10.1016/s0954-6111(96)90134-1. Respir Med. 1996. PMID: 8759481 Free article. No abstract available.

10

Cell-free supernatants of sarcoid alveolar macrophages suppress proliferation of sarcoid alveolar fibroblasts.

Fireman E, Ben Efraim S, Messer G, Dabush S, Greif J, Topilsky M. Fireman E, et al. Among authors: topilsky m. Clin Immunol Immunopathol. 1991 Jun;59(3):368-78. doi: 10.1016/0090-1229(91)90032-6. Clin Immunol Immunopathol. 1991. PMID: 2029791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters